Pesticides and child neurodevelopment

Lisa G Rosas1, Brenda Eskenazi

  • 1University of California at Berkeley, School of Public Health, Center for Children's Environmental Health Research, Berkeley, California, USA.

Insights

In-utero exposure to organochlorine and organophosphate pesticides is linked to impaired child neurodevelopment. Prevention is crucial, especially for those in agricultural areas or with common household pesticide use.

Area of Science:

  • Environmental Health
  • Neuroscience
  • Pediatrics

Background:

  • Pesticide exposure is a potential environmental risk factor for neurodevelopmental disorders.
  • Organochlorine and organophosphate pesticides are commonly used and can cross the placental barrier.

Purpose of the Study:

  • To review recent research on the association between in-utero pesticide exposure and child neurobehavioral development.
  • To focus on organochlorine and organophosphate pesticides.

Main Methods:

  • Literature review of recent studies.
  • Analysis of research on neurodevelopmental outcomes in infants and children following in-utero pesticide exposure.

Main Results:

  • In-utero exposure to dichlorodiphenyltrichloroethane (DDT) and dichlorodiphenyldichloroethene (DDE) is associated with poorer neurodevelopment in infants and children.
  • Organophosphate pesticide exposure in utero may be linked to abnormal neonatal reflexes and negative neurodevelopmental associations in older infants and children.
  • Increased organophosphate exposure in utero was associated with a higher incidence of pervasive developmental disorder in young children.

Conclusions:

  • A link exists between organochlorine and in-utero pesticide exposure and impaired child neurodevelopment.
  • Clinicians should advise parents on preventing pesticide exposure, particularly in high-risk populations.
Abstract

Related Concept Videos

Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Microbial Bioremediation of Pesticides01:28

Microbial Bioremediation of Pesticides

Pesticides often feature structurally complex chemical architectures, incorporating halogen groups and multiple aromatic rings. These characteristics confer high chemical stability, rendering many pesticides resistant to natural degradation processes. This resistance poses significant environmental concerns, as persistent pesticide residues can accumulate in ecosystems and affect non-target organisms.Despite the inherent stability of many pesticides, certain microorganisms possess the metabolic...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...